Barendregt JJ - Search Results

1

Comparative effectiveness of malaria prevention measures: a systematic review and network meta-analysis.

Wangdi K, Furuya-Kanamori L, Clark J, Barendregt JJ, Gatton ML, Banwell C, Kelly GC, Doi SAR, Clements ACA. Wangdi K, et al. Among authors: barendregt jj. Parasit Vectors. 2018 Mar 27;11(1):210. doi: 10.1186/s13071-018-2783-y. Parasit Vectors. 2018. PMID: 29587882 Free PMC article. Review.

2

A generalized pairwise modelling framework for network meta-analysis.

Doi SAR, Barendregt JJ. Doi SAR, et al. Among authors: barendregt jj. Int J Evid Based Healthc. 2018 Dec;16(4):187-194. doi: 10.1097/XEB.0000000000000140. Int J Evid Based Healthc. 2018. PMID: 29621039

3

Meta-analysis of prevalence.

Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Barendregt JJ, et al. J Epidemiol Community Health. 2013 Nov 1;67(11):974-8. doi: 10.1136/jech-2013-203104. Epub 2013 Aug 20. J Epidemiol Community Health. 2013. PMID: 23963506

4

Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?

Stone JC, Furuya-Kanamori L, Barendregt JJ, Doi SA. Stone JC, et al. Among authors: barendregt jj. Pharmacoepidemiol Drug Saf. 2015 Mar;24(3):223-7. doi: 10.1002/pds.3736. Epub 2014 Dec 16. Pharmacoepidemiol Drug Saf. 2015. PMID: 25515780

5

Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model.

Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Doi SA, et al. Among authors: barendregt jj. Contemp Clin Trials. 2015 Nov;45(Pt A):123-9. doi: 10.1016/j.cct.2015.05.010. Epub 2015 May 21. Contemp Clin Trials. 2015. PMID: 26003432

6

Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model.

Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Doi SA, et al. Among authors: barendregt jj. Contemp Clin Trials. 2015 Nov;45(Pt A):130-8. doi: 10.1016/j.cct.2015.05.009. Epub 2015 May 21. Contemp Clin Trials. 2015. PMID: 26003435

7

Meta-analysis in evidence-based healthcare: a paradigm shift away from random effects is overdue.

Doi SAR, Furuya-Kanamori L, Thalib L, Barendregt JJ. Doi SAR, et al. Among authors: barendregt jj. Int J Evid Based Healthc. 2017 Dec;15(4):152-160. doi: 10.1097/XEB.0000000000000125. Int J Evid Based Healthc. 2017. PMID: 29135532

8

A new improved graphical and quantitative method for detecting bias in meta-analysis.

Furuya-Kanamori L, Barendregt JJ, Doi SAR. Furuya-Kanamori L, et al. Among authors: barendregt jj. Int J Evid Based Healthc. 2018 Dec;16(4):195-203. doi: 10.1097/XEB.0000000000000141. Int J Evid Based Healthc. 2018. PMID: 29621038

9

An updated method for risk adjustment in outcomes research.

Doi SA, Barendregt JJ, Rao C. Doi SA, et al. Among authors: barendregt jj. Value Health. 2014 Jul;17(5):629-33. doi: 10.1016/j.jval.2014.05.003. Epub 2014 Jun 23. Value Health. 2014. PMID: 25128057 Free article.

10

Simulation Comparison of the Quality Effects and Random Effects Methods of Meta-analysis.

Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Doi SA, et al. Among authors: barendregt jj. Epidemiology. 2015 Jul;26(4):e42-4. doi: 10.1097/EDE.0000000000000289. Epidemiology. 2015. PMID: 25872162 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page